Categories

IVD

We are an EN ISO 13485 certified EU-located company developing and producing CE IVD real-time PCR kits.

Our in vitro diagnostics fall into five categories: clinical genetics, hematology, pharmacogenetics, oncology and microbiology.

Our typical partners are end-users of the RT-PCR kits (mostly in CZ and SK), business partners and distributors. We are looking for business partners and/or distributors worldwide who can fit the portfolio of our products, either the whole or a part of it, to their sales strategy (see here).

gb GENETIC Gilbert gb GENETIC Gilbert

gb GENETIC Gilbert gb GENETIC Gilbert

The CE IVD real-time PCR kit is intended for detection of polymorphism TA (allele 7TA) in gene UGT1A1 in human genomic DNA. Detection is based on polymerase chain reaction (PCR) with analysis of melting curves using fluorescently labelled probe.

More
gb GENETIC A1AT gb GENETIC A1AT

gb GENETIC A1AT gb GENETIC A1AT

The CE IVD real-time PCR kit is intended for detection of mutations PI*S and PI*Z in the alpha 1 antitrypsin gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
gb GENETIC APOE gb GENETIC APOE

gb GENETIC APOE gb GENETIC APOE

The CE IVD real-time PCR kit is intended for detection of mutations rs429358 and rs7412 in the gene for APOE in human genomic DNA. It enables determination of e2 (cys112, cys158), e3 (cys112, arg158) and e4 (arg112, arg158) genotypes. Examination process is based on a principle of real-time PCR with the use of fluorescently labelled probes (allelic discrimination).

More
gb GENETIC APOB gb GENETIC APOB

gb GENETIC APOB gb GENETIC APOB

The CE IVD real-time PCR kit is intended for detection of mutation R3500Q in the gene APOB in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
gb PHARM DPYD*2A gb PHARM DPYD*2A

gb PHARM DPYD*2A gb PHARM DPYD*2A

The CE IVD real-time PCR kit is intended for detection of mutation DPYD*2A (IVS14+1G>A) in gene for dihydropyrimidine dehydrogenase in human genomic DNA by real-time PCR method (allelic discrimination).

More
gb PHARM CYP2C19 gb PHARM CYP2C19

gb PHARM CYP2C19 gb PHARM CYP2C19

The CE IVD real-time PCR kit is intended for detection of CYP2C19*2, CYP2C19*3 and CYP2C19*17 gene mutation. The detection principle is based on a real-time polymerase chain reaction (qPCR) using fluorescent labeled probes (allelic discrimination).

More
gb PHARM Warfarin gb PHARM Warfarin

gb PHARM Warfarin gb PHARM Warfarin

The CE IVD real-time PCR kit is intended for detection of mutation CYP2C9*2, CYP2C9*3 and VKORC1 G1639A in human genomic DNA by real-time PCR method (allelic discrimination).

More
gb ONCO BCR-ABL MICRO / ABL gb ONCO BCR-ABL MICRO / ABL

gb ONCO BCR-ABL MICRO / ABL gb ONCO BCR-ABL MICRO / ABL

The CE IVD real-time PCR kit enables the quantitative determination of the copy number ratio of the e19a2 (c3a2) transcript of the BCR-ABL1 fusion gene to the copy number of the ABL1 reference gene transcript.

More
gb ONCO BCR-ABL MINOR / ABL gb ONCO BCR-ABL MINOR / ABL

gb ONCO BCR-ABL MINOR / ABL gb ONCO BCR-ABL MINOR / ABL

The CE IVD real-time PCR kit enables the quantitative determination of the copy number ratio of the e1a2 transcript of the BCR-ABL1 fusion gene to the copy number of the ABL1 reference gene transcript.

More
1 2 Next